All stocks ยท LASA
LS

Lasa Supergenerics Limited

LASA BSE Drug Manufacturers - Specialty & Generic Healthcare

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API bulk drug products comprising fenbendazole, toldimphos sodium, cyromazine, aโ€ฆ

ISIN INE670X01014
Listed โ€”
Quarters tracked 13
Filings 14 docs

About

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API bulk drug products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, triciabendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, halquinol, and 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

Key Metrics

as of Sep 2026
Market Cap34 Cr
P/Eโ€”
Div Yield0.00 %
Book Valueโ‚น9.90
52w Highโ‚น14.10
52w Lowโ‚น5.65
Face Valueโ‚น10.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 1.23 -0.13 2.20 3.06 20.01 39.14 33.08 39.39 30.84 22.82 26.66 24.30 30.56
Expenses 2.62 1.99 2.95 7.06 20.51 35.73 32.81 38.60 29.04 26.81 25.60 23.25 26.51
Operating Profit -1.39 -2.12 -0.75 -4.00 -0.50 3.41 0.27 0.79 1.80 -3.99 1.06 1.05 4.05
OPM % -113.01 โ€” -34.09 -130.72 -2.50 8.71 0.82 2.01 5.84 -17.48 3.98 4.32 13.25
Other Income -0.38 -0.42 0.02 0.01 -20.44 -21.52 8.91 1.95 0.00 -8.76 0.00 0.08 0.00
Depreciation 1.57 1.31 1.57 1.57 1.57 3.90 2.80 2.81 2.79 2.66 2.68 2.68 2.65
Interest 0.14 0.13 0.11 0.12 0.03 0.11 0.47 1.24 0.87 0.56 0.44 0.56 0.37
Profit before tax -3.48 -3.98 -2.41 -5.68 -22.54 -22.12 5.91 -1.31 -1.86 -15.97 -2.06 -2.11 1.03
Tax % 3.16 4.77 5.81 10.04 -6.30 -35.40 7.11 146.56 46.77 -4.20 -29.61 -99.05 580.58
Net Profit -3.58 -4.16 -2.55 -6.25 -21.12 -14.29 5.49 -3.23 -2.73 -15.30 -1.46 -0.02 -4.95
EPS in Rs -0.71 -0.83 -0.51 -1.25 -4.22 -2.85 1.10 -0.64 -0.54 -3.05 -0.29 0.00 -0.99

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Sales 25.00142.00104.00130.00137.00201.00167.00170.00244.00199.000.00
Expenses 32.00136.00102.00136.00120.00154.00137.00158.00202.00153.000.00
Operating Profit -7.006.002.00-6.0016.0047.0030.0011.0041.0046.000.00
OPM % -29.004.402.10-4.9012.0024.0018.007.0017.0023.00โ€”
Other Income -21.00-11.00-9.00-18.00-8.000.000.000.003.00-24.000.00
Interest 0.003.002.004.000.002.008.008.0011.0012.000.00
Depreciation 6.0012.0011.0013.0015.0016.0017.0019.0018.008.000.00
Profit before tax -35.00-19.00-19.00-42.00-6.0030.005.00-16.0015.002.000.00
Tax % -2.00-24.0014.00-9.00-13.0023.0023.00-25.0019.00-10.00โ€”
Net Profit -34.00-15.00-22.00-39.00-5.0023.004.00-12.0012.002.000.00
EPS in Rs -6.80-2.95-4.34-7.71-1.315.600.89-5.265.40โ€”โ€”
Dividend Payout % 0.000.000.000.00-24.004.000.000.000.000.00โ€”

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Equity Capital 50.0050.0050.0050.0050.0041.0041.0023.0023.000.050.05
Reserves 0.0034.0047.0068.00108.00118.00101.0082.0094.0075.000.00
Borrowings 10.002.0022.0022.0020.0019.0048.0085.00107.00116.000.00
Other Liabilities 7.0016.0032.0024.0031.0029.0042.0069.0063.0037.000.00
Total Liabilities 66.00102.00151.00164.00209.00208.00232.00258.00287.00228.000.00
Fixed Assets 55.0068.00110.00119.00137.00143.00152.00162.00170.00119.000.00
CWIP 0.000.003.005.005.000.000.007.007.0030.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.00
Other Assets 11.0033.0039.0040.0067.0065.0080.0090.00110.0080.000.00
Total Assets 66.00102.00151.00164.00209.00208.00232.00258.00287.00228.000.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Cash from Operating Activity 0.00-3.002.00-17.009.0041.0014.0041.0040.00-3.000.00
Cash from Investing Activity 0.008.000.0011.00-3.00-4.00-2.00-7.00-44.000.000.00
Cash from Financing Activity 0.00-6.00-2.00-4.000.00-36.00-10.00-33.004.000.000.00
Net Cash Flow 0.000.000.00-10.006.001.002.000.000.00-3.000.00
Free Cash Flow 0.005.000.00-12.0012.0035.0013.0029.00-6.00-5.000.00
CFO/OP % 1.00-45.0096.00273.0073.0087.0046.00397.00103.00-6.00โ€”

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Debtor Days 1.004.0013.007.0050.0027.0045.0062.0063.0064.00
Inventory Days 28.0084.0092.0048.0046.0056.00101.0090.0090.0093.00
Days Payable 32.0035.0068.0032.0068.0041.00130.00170.00102.0071.00
Cash Conversion Cycle -4.0053.0037.0022.0028.0042.0016.00-18.0051.0087.00
Working Capital Days -102.0037.00-44.00-17.0012.0035.00-13.00-52.00-1.0015.00
ROCE % -18.00-1.00-6.00-12.001.0017.007.00-4.0013.0042.00

Shareholding Pattern

% holding โ€” latest first
Holder Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 53.65 53.65 53.65 53.65 53.65 53.65 53.65 53.65 53.65 53.65 53.65 53.65
FIIs 0.00 0.00 0.00 0.47 0.00 0.00 0.01 0.00 0.12 0.01 0.00 0.00
Public 46.35 46.34 46.35 45.88 46.35 46.35 46.32 46.34 46.23 46.33 46.34 46.34
No. of Shareholders 27,702 28,120 28,656 28,115 27,188 27,272 27,968 27,217 27,615 27,161 27,770 28,031

Corporate Actions

7 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Other 20 Sep 2024 โ€” โ€” โ€” Annual General Meeting
Other 20 Sep 2023 โ€” โ€” โ€” Annual General Meeting
Dividend 16 Sep 2022 โ€” โ€” 0.25
Dividend 15 Sep 2021 โ€” โ€” 0.25
Other 17 Sep 2020 โ€” โ€” โ€” Annual General Meeting
Other 19 Sep 2019 โ€” โ€” โ€” Annual General Meeting
Other 17 Sep 2018 โ€” โ€” โ€” Annual General Meeting

Announcements

5 filings